News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Hotter U.S. core CPI lifts odds of a Fed rate hike to 85% for the Sept meeting and pushes Treasury yields up.
  • JPMorgan says the equity risk premium fell to about 2.1%, increasing equities' sensitivity to bond yields and market downside risk.
  • Oklo files a $1 billion at-the-market equity program, and shares fall on investor dilution concerns.
  • Baltic Dry Index drops to its weakest point since Sept 3 as capesize and panamax rates decline, signaling softer bulk demand.
  • Vietnam's competition authority opens a probe into Grab's fares and commissions as drivers plan a weekend walkout, risking service disruption.
  • Brazil's inflation slowed more than expected in August, boosting expectations for another central-bank rate cut next week.

Latest Articles

Northrop Grumman: $7.6B Sentinel Win Tightens the Moat - Mid-Term Trade

Northrop Grumman: $7.6B Sentinel Win Tightens the Moat - Mid-Term Trade

Northrop Grumman's Q2 cadence and a reported $7.6B Sentinel-related surge sharpen program visibility for Space Systems and strategic deterrence work. With solid free cash flow, healthy returns, and bullish technicals, this trade aims to capture further re-rating over the next 45 trading days while protecting against program or macro setbacks.

Equity Bancshares: Buy the Acquisition-Led Growth Dip

Equity Bancshares: Buy the Acquisition-Led Growth Dip

Equity Bancshares (EQBK) is a small regional bank trading near $51 with a clear growth-through-acquisition strategy. Recent M&A and steady loan growth support a case for resuming outperformance; valuation is reasonable on a price-to-book of ~1.28 but P/E and EV/EBITDA are elevated. This trade idea outlines a long entry at $50.94 with a $60 target a…

Buy SCZ - Cheap Exposure to Global Small-Cap Rebound

Buy SCZ - Cheap Exposure to Global Small-Cap Rebound

SCZ (iShares MSCI EAFE Small-Cap ETF) offers broad exposure to Europe, Asia and the Far East small-cap complex at a reasonable valuation, a 3%+ distribution yield and bullish technicals. We prefer a mid-term long trade: entry $86.80, stop $83.00, target $92.00 over 45 trading days.

Q3 Momentum Reaffirms a Swing Trade in Mitek Systems

Q3 Momentum Reaffirms a Swing Trade in Mitek Systems

Mitek Systems (MITK) reported developments around Q3 that strengthen the bull case: improving operating momentum, partnerships expanding biometric capabilities, and a valuation that still leaves room for upside. This is a swing trade idea to capture re-rating into the mid-20s if momentum continues, with strict stop loss to limit downside.

Cresud: Value Recovery Trade After Argentina’s Reforms

Cresud: Value Recovery Trade After Argentina’s Reforms

Cresud (CRESY) remains priced like a beaten-up commodity play despite structural tailwinds from Argentina’s recent reform package and an asset base that should support a meaningful NAV rerating. This trade idea lays out a long-term (180 trading days) tactical long with defined entry, stop and target, plus the catalysts and risks that matter.

Bovespa Retreats as Financials, Utilities and Power Stocks Weigh on Market

Bovespa Retreats as Financials, Utilities and Power Stocks Weigh on Market

Brazil's main stock index, the Bovespa, closed lower on Friday, slipping 1.73% as losses in the Financials, Public Utilities and Electric Power sectors dominated trade. Advancers were outnumbered by decliners, while a key volatility gauge fell to a six-month low. Selected equities showed wide dispersion, with Fleury SA advancing sharply and Lojas R…

River City Bank Lists on Nasdaq After $121.5M Secondary Share Sale

River City Bank Lists on Nasdaq After $121.5M Secondary Share Sale

River City Bank completed the sale of 2.7 million existing shares at $45.00 each, generating roughly $121.5 million in gross proceeds. The transaction was entirely secondary, with holdings sold by members of the bank founder Jon Kelly's family. No new shares were issued and the bank's capital position and ownership composition were not altered. RCB…

Globus Maritime Limited Reports Financial Results for the Second Quarter and Six-Month Period Ended June 30, 2026

Globus Maritime Limited Reports Financial Results for the Second Quarter and Six-Month Period Ended June 30, 2026

Globus Maritime Limited announced solid financial results for Q2 and the first half of 2026, with significant revenue and adjusted EBITDA growth driven by improved market conditions in the dry bulk shipping sector. The company continues operating a fleet of nine dry bulk carriers, primarily on spot and short-term charters, and is nearing completion…

Amwell makes grant to new employees under inducement plan

Amwell makes grant to new employees under inducement plan

Amwell granted restricted stock units (RSUs) totaling 6,679 shares to two new non-executive employees as inducement for joining the company. The RSUs vest over four years, with an initial 25% vesting at one year and the remainder quarterly thereafter. This move follows the company's 2024 Inducement Plan and complies with NYSE rules. Amwell is a lea…

Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference

Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference

Hawkins, Inc., a leading water treatment and specialty ingredients company, announced that its CEO and CFO will participate in Seaport Research Partners’ virtual 15th Annual Summer Investor Conference in August 2026. The event draws over 500 institutional investors and features interactive meetings. Hawkins aims to engage with investors and provide…

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Braveheart Bio, a clinical-stage biopharmaceutical company developing treatments for hypertrophic cardiomyopathy and other cardiovascular diseases, announced the closing of its upsized initial public offering (IPO) of approximately 24.4 million shares at $18.00 each, including full exercise of underwriters' option. The IPO raised $439.9 million gro…